Progression of Metastatic Pancreatic Cancer
5 Views
administrator
07/30/23
George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
-
Category
Show more
Facebook Comments
No comments found